Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastro-Oesophageal Junction Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT05203627
What this trial is testing

Telehealth for the Self-Management of Dietary Quality of Life in Patients After Stomach Cancer Surgery

Who this might be right for
Gastric CarcinomaGastroesophageal Junction Adenocarcinoma
City of Hope Medical Center 53
Large-scale testing (Phase 3)Study completedNCT02545504
What this trial is testing

Andecaliximab With mFOLFOX6 as First Line Treatment for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastric Adenocarcinoma
Gilead Sciences 432
Large-scale testing (Phase 3)Active Not RecruitingNCT05078047
What this trial is testing

Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO

Who this might be right for
Lung Cancer MetastaticRenal Cell CarcinomaHead and Neck Cancer+12 more
UNICANCER 646
Testing effectiveness (Phase 2)Study completedNCT04989816
What this trial is testing

Study of T-DXd Monotherapy in Patients With HER2-expressing Locally Advanced or Metastatic Gastric or GEJ Adenocarcinoma Who Have Received 2 or More Prior Regimens

Who this might be right for
Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
AstraZeneca 95
Testing effectiveness (Phase 2)Study completedNCT00054249
What this trial is testing

T900607 in Treating Patients With Gastroesophageal Junction Cancer

Who this might be right for
Gastric Cancer
University Hospitals Seidman Cancer Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT03641313
What this trial is testing

Berzosertib and Irinotecan in Treating Patients With Progressive, Metastatic, or Unresectable TP53 Mutant Gastric or Gastroesophageal Junction Cancer

Who this might be right for
Clinical Stage III Gastric Cancer AJCC v8Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8Clinical Stage IV Gastric Cancer AJCC v8+5 more
National Cancer Institute (NCI) 17
Testing effectiveness (Phase 2)Study completedNCT00515411
What this trial is testing

Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastroesophageal Junction AdenocarcinomaGastric Cancer
Memorial Sloan Kettering Cancer Center 111
Not applicableApproved For MarketingNCT02307812
What this trial is testing

Ramucirumab Use in Combination With Paclitaxel in Gastric or Gastroesophageal Junction Adenocarcinoma; Temporary Authorization for Use (ATU) in France

Who this might be right for
Gastric CancerGastroesophageal Junction Adenocarcinoma
Eli Lilly and Company
Large-scale testing (Phase 3)Ended earlyNCT05149807
What this trial is testing

Clinical Study of SHR-1701 Plus Chemotherapy as Perioperative Treatment in Subjects With Gastric Cancer

Who this might be right for
Perioperative Treatment in Subjects With Locally Advanced Resectable Gastric Cancer or Gastroesophageal Junction Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 81
Not applicableUnknownNCT01044511
What this trial is testing

Quality of Life With Esophageal Stent Trial

Who this might be right for
Esophageal CancerGastro-esophageal Junction Cancer
Michael Bau Mortensen 80
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07709767
What this trial is testing

Conversion Therapy With Retlirafusp Alfa Plus Chemotherapy in Gastric or Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma
Tang-Du Hospital 21
Early research (Phase 1)Study completedNCT03849469
What this trial is testing

XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors

Who this might be right for
MelanomaCervical CarcinomaPancreatic Carcinoma+20 more
Xencor, Inc. 78
Early research (Phase 1)Study completedNCT02389751
What this trial is testing

Ganetespib in Combination With Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Stage II-III Esophageal Cancer

Who this might be right for
Gastroesophageal Junction AdenocarcinomaMalignant Neoplasm of the Cervical EsophagusMalignant Neoplasm of the Thoracic Esophagus+5 more
M.D. Anderson Cancer Center 3
Testing effectiveness (Phase 2)Ended earlyNCT00080002
What this trial is testing

Efficacy of Pegamotecan (PEG-Camptothecin) in Localized or Metastatic Cancer of the Stomach or Gastroesophageal Junction

Who this might be right for
Cancer of StomachGastroesophageal Cancer
Enzon Pharmaceuticals, Inc.
Not applicableActive Not RecruitingNCT07429318
What this trial is testing

Efficacy and Survival Analysis of Perioperative Treatment of Locally Advanced Gastric or Gastroesophageal Junction Cancer

Who this might be right for
Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 300
Testing effectiveness (Phase 2)Study completedNCT07529613
What this trial is testing

Trastuzumab Deruxtecan Plus Nivolumab Plus Capecitabine Plus Oxaliplatin for HER2 Low Gastric and Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma
National Cancer Center Hospital East 30
Testing effectiveness (Phase 2)Looking for participantsNCT06947291
What this trial is testing

Safety and Efficacy of Glumetinib Combined With Docetaxel for Injection (Albumin-bound) in Patients With Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma and Other Solid Tumors

Who this might be right for
Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma and Other Solid Tumors
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 350
Not applicableLooking for participantsNCT04958720
What this trial is testing

Spanish Registry of Esophagogastric Cancer

Who this might be right for
Esophageal CancerGastric Cancer
Fundación Sociedad Española de Oncologia Médica 10,000
Early research (Phase 1)Ended earlyNCT04144140
What this trial is testing

Study of Intratumorally Administered Stimulator of Interferon Genes (STING) Agonist E7766 in Participants With Advanced Solid Tumors or Lymphomas - INSTAL-101

Who this might be right for
LymphomaAdvanced Solid Tumors
Eisai Inc. 24
Testing effectiveness (Phase 2)Looking for participantsNCT06023758
What this trial is testing

Phase 2 Trial of KN026+KN046±XELOX in HER2-positive Locally Advanced GC

Who this might be right for
HER2-positive Locally Advanced Resectable Gastric Cancer
Peking University 18
Next Page